Pharma Reviews: China's Shanghai Fosun to acquire 86% stake in Gland Pharma for $1.4 billion

MUMBAI: In the first instance of a large foreign investment from China in an Indian manufacturing asset, Shanghai Fosun Pharmaceutical (Group) Co ...
Read more: China's Shanghai Fosun to acquire 86% stake in Gland Pharma for $1.4 billion